-
Mashup Score: 2Early breast cancer: do we need chemotherapy in low genomic/high clinical risk (ER+/HER2-)? - 1 year(s) ago
Lisa Carey, MD, FASCO, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, talks on whether chemotherapy is required in ER+/HER2-…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Hereditary breast cancer at St. Gallen BCC 2023 - 1 year(s) ago
Lisa Carey, MD, FASCO, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, discusses the hereditary breast cancer session during the…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 @DrLisaCarey of @UNC_Lineberger talks on hereditary breast cancer at St. Gallen BCC 2023 Watch: 👉https://t.co/YnyoEZLGB1👈 @SG_BCC #SGBCC2023 #BCSM #BreastCancer
-
-
Mashup Score: 1
Hope S. Rugo, MD, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, discusses what to do in patients with…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 @hoperugo of @UCSFCancer discusses what to do in patients with early-stage TNBC who have not achieved a pCR Watch: 👉https://t.co/fGkPZozJju👈 @SG_BCC #SGBCC2023 #BCSM #BreastCancer
-
-
Mashup Score: 0Reducing inequties in women’s health - 1 year(s) ago
Benjamin Anderson, MD, Fred Hutchinson Cancer Center, Seattle, WA, discusses how health inequities in women’s health can be mitigated, touching…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 @DocBenGlobal of @fredhutch talks on reducing inequities in women’s health Watch: 👉https://t.co/it44So6eYl👈 @SG_BCC #SGBCC2023 #BCSM #BreastCancer
-
-
Mashup Score: 0St Gallen 2023: de-escalation, personalized treatment & adjuvant IO following neoadjuvant IO - 1 year(s) ago
Marleen Kok, MD, PhD, Netherlands Cancer Institute, Amsterdam, Netherlands, discusses the St. Gallen International Breast Cancer Conference, highlighting upcoming sessions…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 Marleen Kok (@lab_kok) of @NKI_nl talks on St Gallen 2023: de-escalation, personalized treatment and the role of adjuvant IO following neoadjuvant IO Watch: 👉https://t.co/SDC66QnyT3👈 @SG_BCC #SGBCC2023 #BCSM #BreastCancer
-
-
Mashup Score: 13 pillars of the WHO Global Breast Cancer Initiative (GBCI) - 1 year(s) ago
Benjamin Anderson, MD, Fred Hutchinson Cancer Center, Seattle, WA, provides an overview of the three pillars in the World Health…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 @DocBenGlobal of @fredhutch discusses 3 pillars of the WHO Global Breast Cancer Initiative (GBCI) Watch: 👉https://t.co/xaf6Y4CAii👈 @SG_BCC #SGBCC2023 #BCSM #BreastCancer
-
-
Mashup Score: 1
Hope S. Rugo, MD, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, discusses optimal neoadjuvant and adjuvant therapy for…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 @hoperugo of @UCSFCancer talks on optimal neoadjuvant and adjuvant therapy for patients with early TNBC Watch: 👉https://t.co/UTYfON3iSo👈 @SG_BCC #SGBCC2023 #BCSM #BreastCancer
-
-
Mashup Score: 0
Icro Meattini, MD, University of Florence, Florence, Italy, outlines accumulating long-term evidence for partial breast irradiation, highlighting long-term results of…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 @Icro_Meattini of @UNI_FIRENZE discusses long-term evidence for partial breast irradiation in early breast cancer Watch: 👉https://t.co/Vi2Wa75Zk3👈 @SG_BCC #SGBCC2023 #BCSM #BreastCancer
-
-
Mashup Score: 1VJOncology – The video journal of oncology - 1 year(s) ago
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of oncology
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
How time flies! It’s been two weeks since #SGBCC2023, check out all of the content and news at https://t.co/ys1d8pDAKO @sg_bcc #BreastCancer #BCsm https://t.co/dR9WHwYiEL
-
-
Mashup Score: 0Personalizing approaches in early-stage TNBC - 1 year(s) ago
Marleen Kok, MD, PhD, Netherlands Cancer Institute, Amsterdam, Netherlands, discusses insights on the latest developments and future prospects of immunotherapy…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 Marleen Kok (@lab_kok) of @NKI_nl talks on personalizing approaches in early-stage TNBC Watch: 👉https://t.co/EMyV9XNKPe👈 @SG_BCC #SGBCC2023 #BCSM #BreastCancer
-
🎥 @DrLisaCarey of @UNC_Lineberger talks on early breast cancer: do we need chemotherapy in low genomic/high clinical risk (ER+/HER2-)? Watch: 👉https://t.co/fqepW2Fy4q👈 @SG_BCC #SGBCC2023 #BCSM #BreastCancer